[Sleep disorders in adolescents and youths with atopic dermatitis and its pharmacologic correction].
Clinical and actographic examinations of various sleep stages in 52 patients with atopic dermatitis have revealed a variety of sleep disturbances in the majority of cases. 56% of the examinees fell asleep with difficulty; it took them 1.5 times longer to fall asleep, vs. the normal subjects. Not deep sleep with frequent awakening at night has been recorded in 67% of the patients, and 42% did not feel rested after night sleep. The type of sleep disturbances depended on the clinical structure of mental disorders, that included asthenic (42%) and depressive (39%) disturbances with explosive, anxiety, and phobic symptoms. Patients with atopic dermatitis should be administered multiple-modality therapy carried out by a dermatologist and a psychiatrist. Besides the drugs for skin condition, psychotropic agents should be administered for 3-4 weeks. Combined therapy of neurotic disorders is most effective with tranquilizers (phenazepam, nitrazepam, radedorm or éunoktin).
Stolbova
S V
SV
Ishutina
N P
NP
Stolbov
V M
VM
D000293:Adolescent; D002908:Chronic Disease; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000503:physiopathology* / Q000523:psychology; D003879:Dermatologic Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D009497:Neurotic Disorders / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D011599:Psychopathology; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012893:Sleep Wake Disorders / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology
D003879:Dermatologic Agents; D011619:Psychotropic Drugs
Narushenie sna u podrostkov i iunosheĭ, bol'nykh atopicheskim dermatitom, i ego farmakologicheskaia korrektsiia.